InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Board Appointment of Leading Pharmaceutical Industry Expert

TRxADE (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company today announced the appointment of Jeff Newell to the company’s board of directors. A previous member of the company’s advisory board, Newell will serve as a strategic resource to TRxADE as it continues to develop its trade relationships in the industry. “We are thrilled to move industry expert, Mr. Newell from our advisory board to our board of directors and look forward to working with him to build stockholder value,” said Suren Ajjarapu, chairman of the board. “We are committed to fostering long-term growth, and we believe we have the leadership in place to achieve that goal. We also believe that the background and experience that Mr. Newell brings to TRxADE is going to be invaluable and expect to benefit from having access to Mr. Newell’s expertise. We are excited about this new relationship.”

To view the full press release, visit https://ibn.fm/RGtXh

About TRxADE Health Inc.

TRxADE is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company operates the TRxADE drug procurement marketplace serving a total of 13,815+ members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient centric telehealth services and tele vet services. For more information on TRxADE Health, please visit the company’s IR website at investors.trxadegroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.